Frankfurt
17.03.25 | 08:52
3,000 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | OPTHEA LIMITED: Notice of Annual General Meeting/Proxy Form | - | ASX | ||
| Mo | Opthea Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| Mo | OPTHEA LIMITED: Opthea Receives A$10.8 million R&D Tax Incentive | 1 | ASX | ||
| 16.09. | OPTHEA LIMITED: Opthea - Annual General Meeting Date | 2 | ASX | ||
| 15.09. | Opthea Ltd - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 15.09. | Opthea Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 15.09. | OPTHEA LIMITED: 2025 Corporate Governance Statement | - | ASX | ||
| 15.09. | OPTHEA LIMITED: Annual Report to shareholders | - | ASX | ||
| OPTHEA LIMITED ADR Aktie jetzt für 0€ handeln | |||||
| 05.09. | OPTHEA LIMITED: S&P DJI Announces September 2025 Quarterly Rebalance | 2 | ASX | ||
| 29.08. | Opthea Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.08. | OPTHEA LIMITED: Preliminary Final Report | - | ASX | ||
| 22.08. | OPTHEA LIMITED: Ceasing to be a substantial holder | 2 | ASX | ||
| 21.08. | OPTHEA LIMITED: Becoming a substantial holder | 1 | ASX | ||
| 20.08. | OPTHEA LIMITED: Corporate Update Investor Call | 1 | ASX | ||
| 19.08. | Opthea, still reeling from eye disease flops, ramps up cuts to 85% of staff and loses CEO | 4 | FierceBiotech | ||
| 19.08. | Opthea Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 19.08. | OPTHEA LIMITED: Application for quotation of securities - OPT | - | ASX | ||
| 19.08. | OPTHEA LIMITED: Opthea Provides Corporate Update | 1 | ASX | ||
| 08.08. | OPTHEA LIMITED: Application for quotation of securities - OPT | 1 | ASX | ||
| 30.07. | Health Check: Opthea investors have $80m less to fight for after cash-burning quarter | 3 | Stockhead |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CORE ONE LABS | 0,079 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.09.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.09.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.09.2025ISIN NameAU000000PEK2 PEAK... ► Artikel lesen | |
| PALATIN TECHNOLOGIES | - | - | Palatin Technologies, Inc.: Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim | Collaboration focused on developing potential first-in-class melanocortin receptor targeted treatment for patients with diabetic retinopathy, including diabetic... ► Artikel lesen | |
| COSCIENS BIOPHARMA | 2,000 | -0,99 % | COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update | COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company's listing on the TSX TORONTO, ONTARIO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma... ► Artikel lesen | |
| HALOZYME THERAPEUTICS | 55,08 | -2,24 % | Strong And Rising: Halozyme Therapeutics Stock May Have More Upside | ||
| AMYRIS | - | - | Amyris gains sole control of Brazilian fermentation facility | ||
| ABCELLERA BIOLOGICS | 4,780 | -6,42 % | Why Did AbCellera's Stock Jump Over 7% After Hours? | ||
| GLOW LIFETECH | 0,026 | 0,00 % | Glow Lifetech to Present at the Annual Smallcap Discoveries Conference in Vancouver | Toronto, Ontario--(Newsfile Corp. - September 24, 2025) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to announce the company is participating in... ► Artikel lesen | |
| BIO-RAD LABORATORIES | 260,10 | +0,04 % | Disruption! Ab jetzt wird alles anders: BioNxt Solutions, BioNTech, Bio-Rad Laboratories | Der Ausbruch der Corona-Pandemie hat vieles verändert. Frei nach dem Motto "Einfach mal machen" setzten Unternehmen wie BioNTech auf die mRNA-Technologie. Der Erfolg inklusive Milliardenumsätzen folgte... ► Artikel lesen | |
| AVID BIOSERVICES | 12,100 | 0,00 % | Avid Bioservices Appoints Kenneth Bilenberg as CEO | ||
| BIOLINERX | 3,365 | -4,94 % | XFRA YP2: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| WHITEHAWK THERAPEUTICS | 1,790 | -5,79 % | Whitehawk Therapeutics, Inc.: Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights | MORRISTOWN, N.J., Aug. 7, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to... ► Artikel lesen | |
| MINERVA NEUROSCIENCES | 2,120 | -5,36 % | Minerva Neurosciences: NBC-Empfehlung knallt +169% über Kaufzone! | Mit der Aktie von Minerva Neurosciences macht ein weiterer Portfolio-Titel des exklusiven No Brainer Club mit anziehenden Handelsumsätzen und steilen Wertzuwächsen auf sich aufmerksam. NBC-Mitglieder... ► Artikel lesen | |
| OVID THERAPEUTICS | 1,430 | -5,30 % | Ovid Therapeutics Inc.: Ovid Therapeutics Announces Pricing of Private Placement Totaling up to $175 Million in Gross Proceeds | NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions with significant... ► Artikel lesen | |
| APPLIED THERAPEUTICS | 0,840 | -7,14 % | Applied Therapeutics Provides Update Following Meeting with FDA | NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the Company), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for... ► Artikel lesen | |
| GEOVAX LABS | 2,685 | -100,00 % | GeoVax Labs, Inc. - 8-K, Current Report |
OPTHEA LIMITED ADR gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 3,000 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu OPTHEA LIMITED ADR finden Sie auf Wallstreet Online.